腎臟病市場規模、佔有率和成長分析（按類型、適應症、診斷、治療方法、年齡層和地區分類）－2026-2033年產業預測

預計到 2024 年，全球腎臟病市場規模將達到 24.2 億美元，到 2025 年將達到 25.4 億美元，到 2033 年將達到 37.8 億美元，在預測期（2026-2033 年）內，複合年成長率為 5.1%。

泌尿系統阻塞（例如腎結石、先天性畸形和腫瘤）發生率的上升，正顯著推動全球腎臟病市場的發展。這些阻塞會導致尿液流動受阻，進而引起腎臟腫脹、組織損傷和腎功能受損。併發症的增加促使患者對診斷和治療方案的需求不斷成長，包括微創技術和手術矯正。生活方式的改變、飲食選擇的改變以及人口老化等因素，都推動了對有效腎臟病管理的需求。此外，超音波、 電腦斷層掃描和MRI等影像技術的進步也發揮關鍵作用，實現了精準的早期診斷。診斷能力的提升進一步推動了對相關醫療設備和手術的需求，從而促進了整體市場成長和投資潛力。

全球腎臟病市場促進因素

全球腎臟病市場成長的主要驅動力是泌尿系統阻塞（包括腎結石、先天性畸形和腫瘤等問題）盛行率的上升。這些疾病會導致尿液儲存，進而引起腎臟腫脹和腎功能受損。這個日益嚴重的健康問題催生了對創新診斷工具和有效治療方案的顯著需求，推動了市場在各個地區的擴張。有效應對這些併發症的迫切需求正在推動治療調查方法的進步，並加速新技術的開發，從而促進全球腎臟病市場的整體成長。

限制全球腎臟病市場的因素

在許多開發中國家，人們對腎臟疾病的認知不足，加上缺乏早期篩檢措施，嚴重阻礙了腎臟病的及時診斷。這種延誤不僅降低了治療方法效果，也限制了對先進診斷和治療方案的整體需求。因此，這些因素對該地區市場成長構成了重大障礙，阻礙了腎腎臟病患者廣泛獲得必要的治療和介入措施。應對這些挑戰對於推動市場擴張和改善與疾病相關的健康狀況至關重要。

全球腎臟病市場趨勢

全球腎臟病市場正日益關注兒童護理，凸顯了治療嬰兒童先天性泌尿道阻塞的必要性。這一轉變得益於人工智慧輔助成像技術和早期篩檢方法的進步，這些技術提高了診斷準確性，並實現了早期療育。隨著醫療機構將兒童的長期腎臟健康置於優先地位，對專業診斷工具和個人化治療方案的需求不斷成長，這推動了創新並擴大了市場機會。這種精準的治療方法不僅改善了患者的預後，還有助於建立一個健全的兒童腎臟病護理生態系統。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

全球腎臟病市場規模（按類型及複合年成長率分類）（2026-2033 年）

• 單側腎臟病
• 雙側腎臟病

全球腎臟病市場規模（按適應症和複合年成長率分類）（2026-2033 年）

• 內源性
  • 急性單側阻塞性泌尿道疾病
  • 腎結石
  • 膀胱癌
  • 膀胱結石
  • 尿道狹窄
  • 骨盆器官脫垂
  • 其他內源性指標
• 外源性
  • 腹膜後纖維化
  • 卵巢靜脈症候群
  • 其他外源性適應症

全球腎臟病市場規模（按診斷和複合年成長率分類）（2026-2033 年）

• 檢查室檢測
  • 尿液檢查
  • 血液常規檢查
  • 電解質分析
  • 其他測試
• 影像診斷
  • 超音波
  • 靜脈腎盂造影
  • KUB X光檢查
  • 電腦斷層掃描
  • 其他影像檢查

全球腎臟病市場規模（依治療方法及複合年成長率分類）（2026-2033 年）

• 體外震波碎石術
• 腹腔鏡
• 膀胱導尿術
• 類固醇療法
• 其他治療方法

全球腎臟病市場規模（依年齡層分類）及複合年成長率（2026-2033 年）

• 成人版
• 兒童

全球腎臟病市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Fresenius Medical Care AG & Co. KGaA（Germany）
• Baxter International Inc.（USA）
• Boston Scientific Corporation（USA）
• B. Braun Melsungen AG（Germany）
• Johnson & Johnson MedTech（USA）
• Medtronic PLC（Ireland）
• Olympus Corporation（Japan）
• Intuitive Surgical（USA）
• Coloplast A/S（Denmark）
• Teleflex Incorporated（USA）
• Becton, Dickinson and Company（BD）（USA）
• Cook Medical（USA）
• Stryker Corporation（USA）
• KARL STORZ SE & Co. KG（Germany）
• Dornier MedTech（Germany/USA）
• Nipro Corporation（Japan）
• Asahi Kasei Corporation（Japan）
• Cardinal Health（USA）
• Convatec Group PLC（UK）
• Richard Wolf GmbH（Germany）

結論與建議

Global Hydronephrosis Market size was valued at USD 2.42 Billion in 2024 and is poised to grow from USD 2.54 Billion in 2025 to USD 3.78 Billion by 2033, growing at a CAGR of 5.1% during the forecast period (2026-2033).

The rising incidence of urinary tract obstructions, such as kidney stones, congenital anomalies, and tumors, significantly propels the global hydronephrosis market. These obstructions lead to urine flow disruption, resulting in kidney swelling, tissue damage, and reduced renal function. As complications mount, there is a growing patient demand for diagnostic and therapeutic solutions, including minimally invasive techniques and surgical corrections. Contributing factors include shifting lifestyles, dietary choices, and an aging demographic, which increase the need for effective hydronephrosis management. Additionally, advancements in imaging technologies like ultrasound, CT scans, and MRI play a pivotal role, allowing for accurate and early diagnosis. This surge in diagnostic capabilities further enhances the demand for related medical devices and procedures, promoting overall market growth and investment potential.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hydronephrosis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Hydronephrosis Market Segments Analysis

Global Hydronephrosis Market is segmented by Type, Indication, Diagnosis, Treatment, Age Group and region. Based on Type, the market is segmented into Unilateral hydronephrosis and Bilateral hydronephrosis. Based on Indication, the market is segmented into Intrinsic and Extrinsic. Based on Diagnosis, the market is segmented into Laboratory tests and Imaging. Based on Treatment, the market is segmented into Shock wave lithotripsy, Laparoscopy, Bladder catheterization, Steroid therapy and Other treatment types. Based on Age Group, the market is segmented into Adult and Pediatric. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Hydronephrosis Market

The global hydronephrosis market is propelled by the rising prevalence of urinary tract obstructions, which encompass issues such as kidney stones, congenital abnormalities, and tumors. These medical conditions lead to the accumulation of urine, resulting in kidney swelling and compromised renal function. This growing health concern creates a significant demand for innovative diagnostic tools and effective therapeutic solutions, thereby stimulating market expansion across various regions. The urgent need to address these complications effectively fosters advancements in treatment methodologies and enhances the development of new technologies, contributing to the overall growth of the hydronephrosis market on a global scale.

Restraints in the Global Hydronephrosis Market

In numerous developing nations, insufficient awareness regarding kidney disorders coupled with a scarcity of early screening initiatives significantly impedes the timely diagnosis of hydronephrosis. This delay in detection not only diminishes the effectiveness of treatment options but also limits the overall demand for advanced diagnostic and therapeutic solutions. As a result, these factors present considerable obstacles to market growth in these areas, hindering the potential for widespread access to necessary care and intervention for those affected by hydronephrosis. Addressing these challenges is essential for fostering market expansion and improving health outcomes related to this condition.

Market Trends of the Global Hydronephrosis Market

The global hydronephrosis market is witnessing a significant trend towards pediatric care, emphasizing the need for addressing congenital urinary tract obstructions in infants and children. This shift is fueled by advancements in AI-assisted imaging technologies and early screening methods that enhance the accuracy of diagnosis and facilitate timely interventions. As healthcare providers prioritize long-term kidney health in the pediatric population, there is a growing demand for specialized diagnostic tools and tailored therapeutic solutions, thereby driving innovation and expanding market opportunities. This targeted approach not only improves patient outcomes but also supports the development of a robust pediatric hydronephrosis care ecosystem.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Hydronephrosis Market Size by Type & CAGR (2026-2033)

• Market Overview
• Unilateral hydronephrosis
• Bilateral hydronephrosis

Global Hydronephrosis Market Size by Indication & CAGR (2026-2033)

• Market Overview
• Intrinsic
  • Acute unilateral obstructive uropathy
  • Kidney stone
  • Bladder cancer
  • Bladder stones
  • Urethral stricture
  • Pelvic organ prolapses
  • Other intrinsic indications
• Extrinsic
  • Retroperitoneal fibrosis
  • Ovarian vein syndrome
  • Other extrinsic indications

Global Hydronephrosis Market Size by Diagnosis & CAGR (2026-2033)

• Market Overview
• Laboratory tests
  • Urinalysis
  • Complete blood count
  • Electrolyte analysis
  • Other laboratory tests
• Imaging
  • Ultrasound
  • Intravenous pyelography
  • KUB X-Rays
  • CT-scan
  • Other imaging types

Global Hydronephrosis Market Size by Treatment & CAGR (2026-2033)

• Market Overview
• Shock wave lithotripsy
• Laparoscopy
• Bladder catheterization
• Steroid therapy
• Other treatment types

Global Hydronephrosis Market Size by Age Group & CAGR (2026-2033)

• Market Overview
• Adult
• Pediatric

Global Hydronephrosis Market Size & CAGR (2026-2033)

• North America (Type, Indication, Diagnosis, Treatment, Age Group)
  • US
  • Canada
• Europe (Type, Indication, Diagnosis, Treatment, Age Group)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Indication, Diagnosis, Treatment, Age Group)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Indication, Diagnosis, Treatment, Age Group)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Indication, Diagnosis, Treatment, Age Group)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Fresenius Medical Care AG & Co. KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson MedTech (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic PLC (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intuitive Surgical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Coloplast A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KARL STORZ SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dornier MedTech (Germany/USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Convatec Group PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Richard Wolf GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations